244 related articles for article (PubMed ID: 35366762)
1. Ruthenium Metallotherapeutics: Novel Approaches to Combatting Parasitic Infections.
Britten NS; Butler JA
Curr Med Chem; 2022 Aug; 29(31):5159-5178. PubMed ID: 35366762
[TBL] [Abstract][Full Text] [Related]
2. Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis.
Sánchez-Delgado RA; Anzellotti A
Mini Rev Med Chem; 2004 Jan; 4(1):23-30. PubMed ID: 14754440
[TBL] [Abstract][Full Text] [Related]
3. 2-Amino-1,3,4-thiadiazoles as prospective agents in trypanosomiasis and other parasitoses.
Serban G
Acta Pharm; 2020 Sep; 70(3):259-290. PubMed ID: 32074064
[TBL] [Abstract][Full Text] [Related]
4. Antiparasitic therapy in children.
Moon TD; Oberhelman RA
Pediatr Clin North Am; 2005 Jun; 52(3):917-48, viii. PubMed ID: 15925668
[TBL] [Abstract][Full Text] [Related]
5. Vanadium compounds as antiparasitic agents: An approach to their mechanisms of action.
Brenda CT; Norma RF; Marcela RL; Nelly LV; Teresa F
J Trace Elem Med Biol; 2023 Jul; 78():127201. PubMed ID: 37210920
[TBL] [Abstract][Full Text] [Related]
6. Antiparasitic therapy.
Kappagoda S; Singh U; Blackburn BG
Mayo Clin Proc; 2011 Jun; 86(6):561-83. PubMed ID: 21628620
[TBL] [Abstract][Full Text] [Related]
7. State-of-the-art Review on the Antiparasitic Activity of Benzimidazolebased Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis.
Francesconi V; Rizzo M; Schenone S; Carbone A; Tonelli M
Curr Med Chem; 2024; 31(15):1955-1982. PubMed ID: 37718524
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.
Mukherjee S; Mukherjee N; Gayen P; Roy P; Babu SP
Curr Drug Metab; 2016; 17(10):937-970. PubMed ID: 27719626
[TBL] [Abstract][Full Text] [Related]
9. Host-directed therapies for parasitic diseases.
Singh B; Varikuti S; Halsey G; Volpedo G; Hamza OM; Satoskar AR
Future Med Chem; 2019 Aug; 11(15):1999-2018. PubMed ID: 31390889
[TBL] [Abstract][Full Text] [Related]
10. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases.
Previti S; Di Chio C; Ettari R; Zappalà M
Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176
[TBL] [Abstract][Full Text] [Related]
11. Curcuma as a parasiticidal agent: a review.
Haddad M; Sauvain M; Deharo E
Planta Med; 2011 Apr; 77(6):672-8. PubMed ID: 21104602
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents.
Ribeiro R; Costa L; Pinto E; Sousa E; Fernandes C
Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132930
[TBL] [Abstract][Full Text] [Related]
13. Potential chemotherapeutic targets in the purine metabolism of parasites.
el Kouni MH
Pharmacol Ther; 2003 Sep; 99(3):283-309. PubMed ID: 12951162
[TBL] [Abstract][Full Text] [Related]
14. Antiparasitic peptides.
Pretzel J; Mohring F; Rahlfs S; Becker K
Adv Biochem Eng Biotechnol; 2013; 135():157-92. PubMed ID: 23615879
[TBL] [Abstract][Full Text] [Related]
15. New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases.
Zucca M; Scutera S; Savoia D
Curr Med Chem; 2013; 20(4):502-26. PubMed ID: 23210775
[TBL] [Abstract][Full Text] [Related]
16. Anti-parasitic Antibodies from Phage Display.
Goulart LR; da S Ribeiro V; Costa-Cruz JM
Adv Exp Med Biol; 2017; 1053():155-171. PubMed ID: 29549639
[TBL] [Abstract][Full Text] [Related]
17. Heme metabolism as a therapeutic target against protozoan parasites.
Lechuga GC; Pereira MCS; Bourguignon SC
J Drug Target; 2019 Aug; 27(7):767-779. PubMed ID: 30332897
[TBL] [Abstract][Full Text] [Related]
18. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.
Date AA; Joshi MD; Patravale VB
Adv Drug Deliv Rev; 2007 Jul; 59(6):505-21. PubMed ID: 17574295
[TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitors in parasitic diseases.
Andrews KT; Haque A; Jones MK
Immunol Cell Biol; 2012 Jan; 90(1):66-77. PubMed ID: 22124373
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance.
Sadr S; Ahmadi Simab P; Niazi M; Yousefsani Z; Lotfalizadeh N; Hajjafari A; Borji H
Expert Rev Anti Infect Ther; 2024 Jun; 22(6):435-451. PubMed ID: 38804866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
